Central Nervous System Neoplasms
📧 Sign up to get email alerts when something new happens for Central Nervous System Neoplasms.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-11-25Clinical Trial Update: Cytochlor, Tetrahydrouridine, and External-Beam Radiation Therapy in Treating Patients With Cancer That Has Spread to the Brain [Phase 1]
A Phase 1 study evaluating Cytochlor and tetrahydrouridine with external-beam radiation therapy for brain and central nervous system tumors …
-
CLINICAL_TRIALS trial_result · 2014-08-22Clinical Trial Update: Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma [Phase 1]
Phase 1 trial evaluating the safety and dosage of combining irinotecan and temozolomide in patients with recurrent primary malignant glioma …
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: Radiation Therapy in Treating Patients With Progressive or Recurrent Malignant Brain Tumors [Phase 2]
A Phase 2 clinical trial evaluating radiation therapy for progressive or recurrent malignant brain tumors has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors [Phase 2]
Phase 2 clinical trial evaluating temozolomide followed by radiation therapy in children with newly diagnosed malignant CNS tumors has compl…
-
CLINICAL_TRIALS trial_result · 2012-07-31Clinical Trial Update: Coproporphyrine Isomers and Methotrexate Elimination
This completed clinical trial update investigates coproporphyrin isomer profiles and methotrexate elimination in patients with Central Nervo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-04-27Clinical Trial Update: Safety Study of High Dose Temozolomide to Treat Relapsed/Refractory Central Nervous System (CNS) Malignancy [Phase 1]
Phase 1 safety study of high-dose temozolomide in relapsed or refractory central nervous system malignancies has been terminated.
-
CLINICAL_TRIALS trial_result · 2011-10-04Clinical Trial Update: Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain Tumor [Phase 2]
Phase 2 clinical trial evaluating irinotecan followed by radiation therapy and temozolomide in children with newly diagnosed brain tumors; s…
-
CLINICAL_TRIALS trial_result · 2011-06-30Clinical Trial Update: Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors [Phase 1]
A Phase 1 trial of topotecan in young patients with neoplastic meningitis due to leukemia, lymphoma, or solid tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2011-03-28Clinical Trial Update: Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain Cancer [Phase 1]
This Phase 1 trial evaluated chemotherapy followed by peripheral stem cell transplantation or bone marrow transplantation in patients with b…
-
CLINICAL_TRIALS trial_result · 2010-06-11Clinical Trial Update: Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma [Phase 1]
This Phase 1 trial of gene therapy and chemotherapy in patients with advanced solid tumors and Non-Hodgkin lymphoma was terminated, with no …
-
CLINICAL_TRIALS trial_result · 2009-07-08Clinical Trial Update: Language Function in Patients With Brain Tumors
Completed clinical trial evaluating language function in patients with brain tumors and other central nervous system neoplasms.